{"schema_version":"secwatch.filing_event.v1","accession":"0000097745-22-000022","form_type":"8-K","ticker":"TMO","cik":"0000097745","company_name":"THERMO FISHER SCIENTIFIC INC.","filed_at":"2022-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.556372+00:00","generated_at":"2026-06-26T03:52:06.586483+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Thermo Fisher Q1 revenue $11.82B (+19%), adjusted EPS $7.25; raises dividend 15%","bullets":["GAAP EPS $5.61 vs $5.88 last year; adjusted EPS $7.25 vs $7.21.","Core organic growth 16%; COVID-19 testing revenue $1.68B.","Repurchased $2.0B of stock and increased dividend by 15%.","PPD clinical research business integration proceeding smoothly.","Moderna entered 15-year strategic collaboration for mRNA manufacturing."],"urls":{"canonical":"https://secwatch.observer/filing/0000097745-22-000022","json":"https://secwatch.observer/filing/0000097745-22-000022.json","markdown":"https://secwatch.observer/filing/0000097745-22-000022.md","text":"https://secwatch.observer/filing/0000097745-22-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/97745/000009774522000022/0000097745-22-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/97745/000009774522000022/tmo-20220428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T03:52:06.586483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}